CPT code 85610 denotes the prothrombin time (PT) laboratory assay, a widely used coagulation test that measures plasma clotting time and monitors anticoagulant therapy such as warfarin. Nationally, PT testing is a routine component of anticoagulation management, perioperative assessment, and workups for bleeding or clotting disorders, making it a high-volume laboratory service with implications for clinical quality and utilization oversight.

Key payers included in the discussion are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical purpose of CPT code 85610, typical sites of service, and the common contexts in which the test is ordered. The publication summarizes benchmark considerations, common billing practices, and policy-relevant issues affecting laboratory reimbursement and prior authorization trends at a national level.

This analysis provides clinicians, laboratory managers, and billing professionals with context on clinical utility, payer coverage patterns, and practical documentation points relevant to CPT code 85610. Data not available in the input will be identified where applicable.